ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.161,01
1,32%
S&P 500
5.099,96
1,02%
Dow Jones
38.239,66
0,40%
Euro vs US Dollar
1,06965
0,00%
Bitcoin
63.420,64
0,01%
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NYSE
  6. Laboratory Corporation of America Holdings (LH)

  7. Laboratory Corporation of America Holdings (LH) News

LH Laboratory Corporation of America Holdings

198,40
0,05 (0,03%)
27 Apr 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Laboratory Corporation of America Holdings LH NYSE Common Stock
  Änderung Änderung % Aktuell Zeit
Upgrade Icon
0,05 0,03% 198,40 02:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
197,08 197,01 200,155 198,40 198,35
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
25.4.202412:58PRNUSLabcorp Announces 2024 First Quarter Results
25.4.202403:27PRNUSLabcorp Announces Winning Bid for Select Assets of Invitae
25.4.202403:19PRNUSInvitae Enters into Agreement with Labcorp for Sale of..
15.4.202413:00PRNUSLabcorp Announces First-of-Its-Kind Test for Early..
11.4.202412:59PRNUSLabcorp Declares Quarterly Dividend
10.4.202412:49PRNUSLabcorp Receives FDA Emergency Use Authorization for Mpox..
08.4.202413:00PRNUSLabcorp Announces Expansion of Precision Oncology Portfolio..
05.4.202413:00PRNUSLabcorp Launches Labcorp® Plasma Detect™ Extending..
02.4.202413:00PRNUSLabcorp to Present Diverse Portfolio of Precision Oncology..
01.4.202414:00BWXcell Biosciences Strengthens Cell and Gene Therapy..
29.3.202414:00PRNUSThe Prelude Network® Names Labcorp Its Preferred Genetic..
28.3.202413:00PRNUSLabcorp Announces Acquisition of Select Assets of..
27.3.202412:00PRNUSLabcorp to Announce First Quarter Financial Results on April..
20.3.202412:00PRNUSLabcorp Launches pTau217 Blood Biomarker Test to Accelerate..
16.3.202415:29PRNUSLabcorp Presents New Research Demonstrating Clinical Impact..
11.3.202413:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11.3.202413:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07.3.202419:16EDGAR2Form 144 - Report of proposed sale of securities
07.3.202416:34EDGAR2Form 144 - Report of proposed sale of securities
07.3.202413:00PRNUSLabcorp Launches Weight Loss Management Testing Solutions
22.2.202421:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22.2.202421:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21.2.202422:35EDGAR2Form 144 - Report of proposed sale of securities
21.2.202420:38EDGAR2Form 144 - Report of proposed sale of securities
21.2.202414:19GLOBEDiagnostics Industry Leader Gary Huff Appointed to Biomerica..
15.2.202414:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15.2.202413:01EDGAR2Form 8-K - Current report
15.2.202412:56PRNUSLabcorp Announces 2023 Fourth Quarter and Full Year Results
13.2.202418:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.2.202418:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.2.202418:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.2.202418:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.2.202418:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.2.202418:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.2.202418:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.2.202418:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.2.202418:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.2.202416:24EDGAR2Form 144 - Report of proposed sale of securities
09.2.202418:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.2.202421:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.2.202421:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.2.202421:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.2.202421:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.2.202421:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.2.202421:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.2.202421:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.2.202421:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.2.202421:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.2.202421:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.2.202421:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Kürzlich von Ihnen besucht

NYSE
LH
Laboratory Corporation o...
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten